Application no. and date | 14752705.5 (espacenet) (Federated) (European Patent Register), 20140731 | Patent/reg. no. and date | DK/EP 3027651, 20190227 | Publication date | 20160608 | Priority no. and date | US 201361861198 P, 20130801, US 201361901732 P, 20131108, US 201461933632 P, 20140130 | EP pub. no. and date |
EP 3027651 20160608 | Effective date | | Applicant/owner | Five Prime Therapeutics, Inc., 111 Oyster Point Boulevard
South San Francisco, CA 94080, US | Applicant ref. no. | T5891_DK | Inventor | HARDING, Thomas, Two Corporate Drive
South San Francisco California 94080, US, BRENNAN, Thomas, Two Corporate Drive
South San Francisco California 94080, US, PIERCE, Kristen, Two Corporate Drive
South San Francisco California 94080, US, PATIL, Namrata, Two Corporate Drive
South San Francisco California 94080, US, HAMBLETON, Julie, Two Corporate Drive
South San Francisco California 94080, US | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | Opponent | | IPC Class | A61K 31/337 (2006.01) , A61K 31/513 (2006.01) , A61K 33/24 (2019.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , C07K 16/28 (2006.01) | Title | AFUCOSYLEREDE ANTI-FGFR2IIIB-ANTISTOFFER | Int. application no. | US2014049008 | Int. publication no. | WO2015017600 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|